skip to Main Content
Our Purpose

The purpose of the International Diabetes Association (IDA) is to help Type 2 Diabetics reverse their disease with proper lifestyle changes.

Type 2 Diabetes is an international health crisis. Until we embrace diabetes reversal as the preferred treatment over diabetes “management”, statistics like the ones below will only continue to worsen.
Diabetes reversal is available to all Type 2 diabetics. A patient can reverse their diabetes, regardless of how long they’ve been diabetic. At the IDA, we are dedicated to helping diabetics from all walks of life reverse this disease. But we need your help.

Prevalence of Type 2 Diabetes in the U.S.

According to the 2017 National Diabetes Statistics Report by the CDC:

  • 30.3 million Americans have diabetes (9.4% of the population)
  • 23.1 million have been diagnosed
  • 7.2 million are undiagnosed (23.8% of Type 2 diabetics are undiagnosed)
  • The total direct and indirect estimated cost of diagnosed diabetes in the United States in 2012 was $245 billion.

Type 2 Diabetes & Heart Disease

  • At least 68%of people age 65 or older with diabetes die from some form of heart disease; and 16% die of stroke.
  • Adults with diabetes are 2 to 4 times more likely to die from heart disease than adults without diabetes.
  • Women with diabetes have a 40% greater risk of developing heart disease and a 25% greater risk of stroke than men with diabetes do.

Type 2 Diabetes & Neuropathy

  • About 60% to 70% of diabetics eventually develop peripheral neuropathy, or nerve damage.
  • Neuropathy is the first sign that a patient is in danger of eventually requiring an amputation.

Type 2 Diabetes & Amputation

According to the American Journal of Managed Care:

  • The rate of amputations increased by 50% between 2009 and 2015
  • Every day 230 Americans with diabetes will suffer an amputation
  • Throughout the world, it is estimated that every 30 seconds a leg is amputated. And 85% of these amputations were the result of a diabetic foot ulcer.

Type 2 Diabetes & Blindness

  • Diabetic retinopathy is the most frequent cause of new cases of blindness among adults aged 20–74 years.
  • In a recent study conducted at the CDC, 4.2 million adults had Diabetic Retinopathy (DR) and 655,000 had vision-threatening DR.
  • The more severe, vision-threatening form of the disease was more than twice as common in Mexican Americans, and almost three times as common in African-Americans, than in the white population.

Type 2 Diabetes & Kidney Disease

  • More than 35% of people aged 20 years or older with diabetes have chronic kidney disease.
  • End stage renal disease is increasing in the United States by 5% per year.
  • Over 247,000 people are currently living with kidney failure resulting from diabetes.
  • The need for donor kidneys is rising at 8% per year, yet their availability has not grown to match.
  • There are more than 100,000 ESRD patients on the U.S. transplant wait list. Yet in 2016, only 20,161 kidney transplants were performed in the United States.
  • Dialysis treatment costs an average of $89,000 per patient annually in the United States.
  • Only 35% of dialysis patients remain alive after five years of treatment.

The Staggering Cost of Type 2 Diabetes

According to a study in the American Journal of Preventive Medicine, “In men diagnosed with type 2 diabetes at ages 25-44 years, 45-54 years, 55-64 years, and ≥ 65 years, the lifetime direct medical costs of treating type 2 diabetes and diabetic complications were $124,700, $106,200, $84,000, and $54,700, respectively. In women, the costs were $130,800, $110,400, $85,500, and $56,600, respectively.

The age-gender weighted average of the lifetime medical costs was $85,200, of which 53% was due to treating diabetic complications. The cost of managing macrovascular complications accounted for 57% of the total complication cost.

The conclusion? “Over the lifetime, Type 2 Diabetes imposes a substantial economic burden on healthcare systems.”

Type 2 Diabetes Around The World

According to the World Health Organization:

  • The global prevalence of diabetes among adults over 18 years of age has almost doubled from 4.7% in 1980 to 8.5% in 2014
  • The  total  burden of  deaths from  high blood glucose 1  in 2012 has been estimated  to amount to 3.7 million. This  number includes 1.5 million diabetes deaths, and an additional 2.2 million deaths from cardiovascular  diseases, chronic kidney disease, and tuberculosis related to higher-than-optimal blood glucose.
  • One  study  estimates  that losses  in GDP worldwide  from 2011 to 2030, including both the direct and indirect costs of diabetes, will total $ 1.7 trillion, comprising $900 billion  for high-income countries and $800 billion for low and middle income countries.
Back To Top
×Close search